内部人交易雷达

构建时间: 2026-10-19T16:10:32+00:00 · English

披露摘要

2026-W33 周披露的美国内部人买入

2026-08-10 至 2026-08-16. 208 家公司、376 名买方共 421 条买入披露;申报金额 $1.2bn。

条买入披露
421
家公司
208
名买方
376
申报金额
$1.2bn

按公司汇总的最大申报买入

公司代码买方披露条数申报金额
REPUBLIC SERVICES, INC.RSG24$373.0M
Braveheart Bio, Inc.BRVE88$218.9M
Audax Private Credit Fund, LLCNONE77$101.8M
Attovia Therapeutics, Inc.ATTO1010$99.1M
BlossomHill Therapeutics, Inc.BLSM1212$60.2M
51Talk Online Education GroupCOE13$33.3M
QVC Group, Inc.QVCG33$30.0M
Pinnacle Acquisition CorpPNAQ66$29.8M
West Bay BDC LLCNONE11$27.0M
Crescent Private Credit Income Corp55$17.8M
Latigo Biotherapeutics, Inc.LTGO77$17.6M
Liberty Capital Corp/NVGLIBK11$13.6M
NATURES SUNSHINE PRODUCTS INCNATR55$11.6M
ProFrac Holding Corp.ACDC44$11.3M
HPS Real Assets Lending Co LPNONE44$11.0M
INTEL CORPINTC11$10.0M
Empery Digital Inc.EMPD22$8.1M
American Assets Trust, Inc.AAT12$7.8M
Borr Drilling LtdBORR22$6.5M
TXO Partners, L.P.TXO12$5.6M
Privacore VPC Asset Backed Credit FundNONE11$5.0M
Outlook Therapeutics, Inc.OTLK22$5.0M
Liberty Latin America Ltd.LILA23$3.7M
Aptiv PLCAPTV22$3.1M
Chiron Real Estate Inc.XRN36$2.5M

有两名及以上买方的公司

公司代码买方披露条数申报金额
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTDTSM3030$118.9k
BlossomHill Therapeutics, Inc.BLSM1212$60.2M
Attovia Therapeutics, Inc.ATTO1010$99.1M
Braveheart Bio, Inc.BRVE88$218.9M
Audax Private Credit Fund, LLCNONE77$101.8M
Latigo Biotherapeutics, Inc.LTGO77$17.6M
Chemours CoCC77$488.6k
Pinnacle Acquisition CorpPNAQ66$29.8M
Crescent Private Credit Income Corp55$17.8M
NATURES SUNSHINE PRODUCTS INCNATR55$11.6M
Amrize LtdAMRZ55$838.9k
Hepion Pharmaceuticals, Inc.HEPA55$825.0k
KEMPER CorpKMPR55$367.9k
FEMASYS INCFEMY55$134.0k
ProFrac Holding Corp.ACDC44$11.3M
HPS Real Assets Lending Co LPNONE44$11.0M
Compass Diversified HoldingsCODI44$1.5M
Embecta Corp.EMBC44$557.9k
JEWETT CAMERON TRADING CO LTDJCTC44$139.1k
BANK OF THE JAMES FINANCIAL GROUP INCBOTJ44$34.7k
QVC Group, Inc.QVCG33$30.0M
Chiron Real Estate Inc.XRN36$2.5M
Infleqtion, Inc.INFQ33$1.9M
CROSS TIMBERS ROYALTY TRUSTCRT33$783.6k
SOLITRON DEVICES INCSODI33$684.0k

按买方角色

买方角色家公司披露条数申报金额
10% 股东3893$720.3M
董事110147$272.1M
其他619$85.0M
首席执行官5768$80.3M
Executive Chairman46$9.0M
首席财务官1515$2.2M
高管1013$1.3M
See Remarks57$711.7k
COO11$495.9k
CLO, CCO, CAO & Corp Sec11$197.8k
VP, CAO & Assistant Treasurer11$150.6k
SVP, Treasury, Tax & CAO11$107.5k
Pres, Pharm Svc&Prod Mgmt, CLO11$99.8k
SVP - Acetyls11$98.0k
总裁55$88.4k
General Counsel11$74.7k
VP116$55.3k
General Counsel/Secretary11$53.3k
Treasurer11$53.3k
EVP, Reservoir Engineering11$43.3k
SVP & GC11$27.4k
EVP, Sec. & General Counsel11$26.5k
SEE REMARKS11$25.7k
Chief Actuary11$20.6k
SVP15$20.3k
EVP and Co-COO12$10.6k
Chief Clinical-Medical Affairs11$10.0k
SVP and Deputy Co-COO12$9.2k
VP,Treasurer, Asst. Corp. Sec.11$5.8k
SVP and GC11$4.2k
VP and CIO11$3.6k
Controller11$2.4k
EVP/CRDEO11$1.3k
Secretary and CCO11$1.0k
EXEC. CHAIR & PRINCIPAL OFF12$861

买入指按本站美国筛选规则认定的 Form 4 公开市场买入(代码 P)且为合资格股票;授予、期权行权、赠与和衍生品均已排除。金额为申报值,以美元计。本页不使用任何分数或排名。